Expected current-year loss or profit decline

We expect to record a net loss in 2026, primarily due to share-based payment expenses and continued investment in research and development as we further expand our business operations, and listing expenses.

Summary · p. 21

We also expect our financial performance in 2026 to continue to be affected by non-cash changes in the carrying amount of our redemption liabilities.

Summary · p. 21

We expect a net loss in 2026 primarily due to expected increases in (i) R&D expenses in relation to our pipeline drugs; and (ii) expenses in connection with the [REDACTED] incurred in 2026.

Summary · p. 13

Our loss for FY2026 is expected to continue, mainly due to (i) an increase in our general and administrative expenses, driven by our Listing expenses; and (ii) an increase in our research and development expenses.

Summary · p. 12

Our Directors confirm that, up to the date of this prospectus, there has been no material changes to our business model and the general economic and regulatory environment in which we operate, there has been no material adverse change in our financial or trading position or prospects since 31 March 2026, being the date of the latest audited consolidated financial position of our Group as set out in the Accountants' Report in Appendix I to this document.

Summary · p. 12

We expect to incur a net loss in 2026, primarily attributable to our continued investment in research and development and business expansion.

Summary · p. 19

Furthermore, we expect to incur [REDACTED] in connection with the [REDACTED] and equity-settled share-based payments.

Summary · p. 19

We expect that there will be a significant increase in our net loss in 2026, primarily due to (i) an increase in research and development expenses including professional services expenses to be paid to clinical service providers, and costs of purchasing materials and consumables to be used in clinical trials in preparation for the planned commencements of multiple Phase III clinical trials, and (ii) an increase in staff costs, mainly driven by an increase in share-based compensation expenses arising from the share-based compensation granted in November 2025.

Summary · p. 17

Our Directors confirm that up to the date of this prospectus, there had been no material adverse change in our financial, operational or prospects since March 31, 2026, being the latest balance sheet date of our consolidated financial statements as set out in the Accountants’ Report in Appendix I to this prospectus.

Summary · p. 13

Nevertheless, we expect our net profit for 2026 to decrease as compared with 2025, primarily due to equity-settled share-based payments and listing expenses.

Summary · p. 13

In light of the above, we expect to record a loss for the year ending December 31, 2026.

Summary · p. 14

In 2026, we expect the ASP of our existing chip products to further decrease as compared with 2025, primarily due to continued price competition in mature cellular IoT chip categories, customers’ cost optimization requirements and the continuing commercialization cycle of NB-IoT and Cat.1bis products.

Summary · p. 13

Commencing in August 2026, we received formal purchase orders for the EC800L, with orders reaching 120,000 units in the first month of order receipt, laying a solid foundation for volume scaling in the second half of 2026.

Summary · p. 13

We expect to incur net losses for the year ending December 31, 2026, mainly because we expect to continually incur (i) significant research and development expenses, as we will continue to devote resources to develop and enhance our intelligent robotic technologies; (ii) substantial selling expenses, as we continue allocate significant resources in expanding and strengthening our sales network to prepare for global commercial deployment of our products, despite our efforts to drive revenue growth, improve gross profit margin and enhance operating leverage in the year ending December 31, 2026.

Summary · p. 13

Our net losses for the year ending December 31, 2026 will also be affected by changes in the carrying amount of redemption liabilities.

Summary · p. 13

We expect to record a net loss for the year ending December 31, 2026, which is primarily due to our expectation that significant research and development costs and administrative expenses will be further incurred.

Summary · p. 14

We anticipate that our net profit may decline for the year ending December 31, 2026 compared with 2025, primarily attributable to an expected decrease in revenue contribution from our acoustic enhancement materials as well as an expected increase in share-based payments and [REDACTED] expenses, partially offset by growth in other product categories.

Summary · p. 13

According to Frost & Sullivan, the potential decline in revenue contribution from acoustic enhancement materials is primarily attributable to expected lower shipments of certain Android smartphone brands, reflecting cyclical changes in downstream industries.

Summary · p. 13

The slowdown of consumer electronics industry in 2026 may adversely affect our revenue and profitability in the short term.

Financial Information · p. 188

We expect to record a net loss for the year ending December 31, 2026, primarily due to

Summary · p. 17

(i) our continued investment in research and development to advance the development and enhancement of our AI-related technologies and solutions, which resulted in increased research and development expenses; and (ii) increased sales and marketing expenses as we continued to expand our business and market presence.

Summary · p. 17

For the six months ended June 30, 2025 and 2026, our adjusted net loss (non-IFRS measures) increased by 34.9% from RMB42.1 million to RMB56.8 million, primarily reflecting our increased investment in research and development and selling and distribution activities as we continued to expand our business.

Financial Information · p. 222

our Directors expect to record net loss of approximately RMB21.4 million in 2026, primarily due to the increased [REDACTED] in 2026.

Financial Information · p. 260

After excluding the [REDACTED], we expected to record an adjusted net profit of approximately RMB6.9 million in 2026.

Financial Information · p. 260

Therefore, our Directors are of the view, and nothing has come to the attention of the Sole Sponsor to cast doubt on such Directors’ view, that the Company’s business is sustainable notwithstanding the forecast net loss in 2026.

Financial Information · p. 260

In April 2026, we invested in certain listed securities and recorded a significant fair value gain as of the Latest Practicable Date.

Summary · p. 11

As a result, even if our revenue continues to grow in 2026, our net profit and net profit margin might decline in 2026.

Summary · p. 11

Our Directors confirm that, up to the date of this document, except for the foregoing, there has been no material adverse change in our business, financial condition and results of operations since March 31, 2026, which is the end date of the period reported on in the Accountants’ Report in Appendix I to this document, and there is no event since March 31, 2026 which would materially affect the information as set out in the Accountants’ Report in Appendix I to this document.

Summary · p. 11

We expect to incur an increase in net loss for the year ending December 31, 2026, which is primarily due to our expectations that we will continue to incur significant research and development expenses, administrative expenses, including increase in expenses incurred in relation to the [REDACTED], and other expenses in relation to our ongoing operations.

Summary · p. 17

After performing due diligence work which our Directors consider appropriate and sufficient and after due and careful consideration, our Directors confirm that there has been no material adverse change in our business, financial condition and results of operations since May 31, 2026, being the latest balance sheet date of our consolidated financial statements in the Accountants’ Report set out in Appendix I to this Document, and up to the date of this Document.

Summary · p. 17

We expect to continue to record net losses in 2026, primarily due to our ongoing investments in research and development, administrative expenses associated with business expansion and organizational build-out, customer program ramp-up and other initiatives to support long-term growth and scale-up of our business.

Summary · p. 19

We have maintained robust growth in business operations and financial results since May 31, 2026 and up to the Latest Practicable Date.

Summary · p. 19

Notwithstanding the expected improvement in our operating performance, our net profit/loss position for 2026 will be affected by non-cash share-based compensation expenses, the amount of which may fluctuate depending on the fair value of the underlying equity interests, continued investment in research and development expenses and [REDACTED] expenses.

Summary · p. 19

Accordingly, we anticipate to record a net loss for the year ending December 31, 2026.

Summary · p. 19

Notwithstanding the above progress and the improvement in our gross margin performance, we expect to record a net loss for the year ending December 31, 2026.

Summary · p. 15

This is primarily because the gross profit contribution from our equipment sales, operational services and emerging application scenarios is expected to remain insufficient to fully cover our operating expenses, including selling and marketing expenses, administrative expenses and R&D expenses, as we continue to support technology development, customer expansion and overseas market exploration.

Summary · p. 15

The net loss for four months ended April 30, 2026 increased compared to four months ended April 30, 2025, primarily due to (i) increased finance costs arising from imputed interest on redemption right liabilities associated with our [REDACTED] financing, and (ii) increased administrative expenses arising from employee compensations and depreciation and amortization.

Summary · p. 13

We expect to record a net loss for the year ending 31 December 2026, primarily driven by continued investment in research and development activities.

Summary · p. 13

While our overall business operations remained relatively stable, we expect to record a slight decrease of our net profit in 2026 compared to 2025, primarily attributable to an expected increase in depreciation costs from our newly constructed production facility.

Summary · p. 14

We expect to record an increase in net loss in 2026, primarily due to (i) the plan to implement a new employee equity incentive plan to align the interests of employees and appeal to skilled professionals, encouraging employees to focus on sustainable financial growth and long-term gains, and (ii) the increase in [REDACTED].

Summary · p. 20

Nevertheless, we are working on gradually decreasing the net losses through management on various expenses.

Summary · p. 20